299 related articles for article (PubMed ID: 27743433)
21. Relationship between measures of central and general adiposity with aortic stiffness in the general population.
Wohlfahrt P; Somers VK; Cifkova R; Filipovsky J; Seidlerova J; Krajcoviechova A; Sochor O; Kullo IJ; Lopez-Jimenez F
Atherosclerosis; 2014 Aug; 235(2):625-31. PubMed ID: 24968316
[TBL] [Abstract][Full Text] [Related]
22. Serum CETP concentration is not associated with measures of body fat: The NEO study.
Blauw LL; de Mutsert R; Lamb HJ; de Roos A; Rosendaal FR; Jukema JW; Wang Y; van Dijk KW; Rensen PC
Atherosclerosis; 2016 Mar; 246():267-73. PubMed ID: 26820801
[TBL] [Abstract][Full Text] [Related]
23. Anthropometric measurements as predictors of intraabdominal fat thickness.
Roopakala MS; Suresh A; Ashtalakshmi ; Srinath ; Ashok ; Giridhar ; Anand ; Silvia WD
Indian J Physiol Pharmacol; 2009; 53(3):259-64. PubMed ID: 20329373
[TBL] [Abstract][Full Text] [Related]
24. Visceral fat is associated with the racial differences in liver fat between black and white adolescent boys with obesity.
Lee S; Kuk JL
Pediatr Diabetes; 2017 Nov; 18(7):660-663. PubMed ID: 28176415
[TBL] [Abstract][Full Text] [Related]
25. Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk Samsung Health Study.
Lee MK; Park HJ; Jeon WS; Park SE; Park CY; Lee WY; Oh KW; Park SW; Rhee EJ
Cardiovasc Diabetol; 2015 Jul; 14():88. PubMed ID: 26169265
[TBL] [Abstract][Full Text] [Related]
26. Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index.
Pang Q; Zhang JY; Song SD; Qu K; Xu XS; Liu SS; Liu C
World J Gastroenterol; 2015 Feb; 21(5):1650-62. PubMed ID: 25663786
[TBL] [Abstract][Full Text] [Related]
27. Nonalcoholic Fatty Liver: The Association with Metabolic Abnormalities, Body Mass Index and Central Obesity--A Population-Based Study.
Ostovaneh MR; Zamani F; Ansari-Moghaddam A; Sharafkhah M; Saeedian FS; Rohani Z; Khoonsari M; Barzin G; Hemmasi G; Ajdarkosh H; Katoonizadeh A; Maadi M; Malekzadeh R; Poustchi H
Metab Syndr Relat Disord; 2015 Sep; 13(7):304-11. PubMed ID: 26042518
[TBL] [Abstract][Full Text] [Related]
28. A Val227Ala substitution in the peroxisome proliferator activated receptor alpha (PPAR alpha) gene associated with non-alcoholic fatty liver disease and decreased waist circumference and waist-to-hip ratio.
Chen S; Li Y; Li S; Yu C
J Gastroenterol Hepatol; 2008 Sep; 23(9):1415-8. PubMed ID: 18853997
[TBL] [Abstract][Full Text] [Related]
29. Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study.
Naderian M; Kolahdoozan S; Sharifi AS; Garmaroudi G; Yaseri M; Poustchi H; Sohrabpour AA
Arch Iran Med; 2017 Apr; 20(4):211-217. PubMed ID: 28412824
[TBL] [Abstract][Full Text] [Related]
30. Waist-to-height ratio: an accurate anthropometric index of abdominal adiposity and a predictor of high HOMA-IR values in nondialyzed chronic kidney disease patients.
Silva MI; Lemos CC; Torres MR; Bregman R
Nutrition; 2014 Mar; 30(3):279-85. PubMed ID: 24332526
[TBL] [Abstract][Full Text] [Related]
31. Liver enzyme levels and hepatic iron content in Fatty liver: a noninvasive assessment in general population by T2* mapping.
Radmard AR; Poustchi H; Dadgostar M; Yoonessi A; Kooraki S; Jafari E; Hashemi Taheri AP; Malekzadeh R; Merat S
Acad Radiol; 2015 Jun; 22(6):714-21. PubMed ID: 25754799
[TBL] [Abstract][Full Text] [Related]
32. [Non-invasive markers of fibrosis in the diagnosis of non-alcoholic fatty liver disease].
Arteaga I; Buezo I; Expósito C; Pera G; Rodríguez L; Alumà A; Auladell MA; Torán P; Caballería L
Gastroenterol Hepatol; 2014 Nov; 37(9):503-10. PubMed ID: 24746708
[TBL] [Abstract][Full Text] [Related]
33. Ultrasound/Elastography techniques, lipidomic and blood markers compared to Magnetic Resonance Imaging in non-alcoholic fatty liver disease adults.
Cantero I; Elorz M; Abete I; Marin BA; Herrero JI; Monreal JI; Benito A; Quiroga J; Martínez A; Huarte MP; Uriz-Otano JI; Tur JA; Kearney J; Martinez JA; Zulet MA
Int J Med Sci; 2019; 16(1):75-83. PubMed ID: 30662331
[TBL] [Abstract][Full Text] [Related]
34. Obesity and Abdominal Fat Markers in Patients with a History of Stroke and Transient Ischemic Attacks.
Winter Y; Pieper L; Klotsche J; Riedel O; Wittchen HU
J Stroke Cerebrovasc Dis; 2016 May; 25(5):1141-1147. PubMed ID: 26915603
[TBL] [Abstract][Full Text] [Related]
35. Visceral adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome.
Vassilatou E; Lafoyianni S; Vassiliadi DA; Ioannidis D; Paschou SA; Mizamtsidi M; Panagou M; Vryonidou A
Maturitas; 2018 Oct; 116():1-7. PubMed ID: 30244768
[TBL] [Abstract][Full Text] [Related]
36. Associations Between Abdominal Obesity Indices and Nonalcoholic Fatty Liver Disease: Chinese Visceral Adiposity Index.
Chen X; Shi F; Xiao J; Huang F; Cheng F; Wang L; Ju Y; Zhou Y; Jia H
Front Endocrinol (Lausanne); 2022; 13():831960. PubMed ID: 35360076
[TBL] [Abstract][Full Text] [Related]
37. Waist circumference, waist-to-hip ratio and waist-to-height ratio reference percentiles for abdominal obesity among Greek adolescents.
Bacopoulou F; Efthymiou V; Landis G; Rentoumis A; Chrousos GP
BMC Pediatr; 2015 May; 15():50. PubMed ID: 25935716
[TBL] [Abstract][Full Text] [Related]
38. Anthropometric clinical indicators of visceral adiposity as predictors of nonalcoholic fatty liver disease.
Almeida NS; Rocha R; Daltro C; Souza CA; Silva RLPD; Sarno MAC; Cotrim HP
Rev Assoc Med Bras (1992); 2021 Nov; 67(11):1544-1549. PubMed ID: 34909876
[TBL] [Abstract][Full Text] [Related]
39. Non-resolution of non-alcoholic fatty liver disease (NAFLD) among urban, adult Sri Lankans in the general population: A prospective, cohort follow-up study.
Niriella MA; Kasturiratna A; Beddage T; Ediriweera DS; De Silva ST; Perera KR; Subasinghe CE; Kodisinghe SK; Piyaratna TC; Rishikesawan V; Dassanayaka AS; De Silva AP; Pathmeswaran A; Wickramasinghe AR; Kato N; Janaka de Silva H
PLoS One; 2019; 14(10):e0224474. PubMed ID: 31661524
[TBL] [Abstract][Full Text] [Related]
40. Visceral and subcutaneous abdominal fat is associated with non-alcoholic fatty liver disease while augmenting Metabolic Syndrome's effect on non-alcoholic fatty liver disease: A cross-sectional study of NHANES 2017-2018.
Elguezabal Rodelo RG; Porchia LM; Torres-Rasgado E; López-Bayghen E; Gonzalez-Mejia ME
PLoS One; 2024; 19(2):e0298662. PubMed ID: 38394065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
